Welcome to the UPF Digital Repository
Browsing by Author "Carballo Martínez, Núria"
- Home
- →
- Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Author "Carballo Martínez, Núria"
Now showing items 1-10 of 10
-
González-García, José Gregorio; Chalela Rengifo, Roberto José, 1985-; Carballo Martínez, Núria; Ausín Herrero, Pilar, 1974- (Elsevier, 2020)
-
González-García, José Gregorio; Chalela Rengifo, Roberto José, 1985-; Carballo Martínez, Núria; Ausín Herrero, Pilar, 1974- (Elsevier, 2020)
-
Climente-Martí, Mónica; Ausín Herrero, Pilar, 1974-; Carballo Martínez, Núria; Merino-Bohórquez, Vicente; Gómez-Bastero, Ana; López-García, Víctor Manuel (Sociedad Española de Farmacia Hospitalaria, 2020)As one of the most prevalent chronic respiratory diseases, asthma imposes a heavy health and socioeconomic burden on society, particularly in the case of patients who fail to appropriately control the disease. For this ...
-
Carballo Martínez, Núria; De Antonio Cuscó, Marta; Echeverría Esnal, Daniel; Luque Pardos, Sònia; Salas Sanchez, Esther; Grau Cerrato, Santiago (Sociedad Española de Farmacia Hospitalaria, 2017)INTRODUCTION: Community-acquired pneumonia (CAP) is associated with high morbidity and mortality rates. Despite methicillin-resistant Staphylococcus aureus (MRSA) having often been associated with nosocomial pneumonia, the ...
-
Barceló-Vidal, Jaime; Echeverría Esnal, Daniel; Carballo Martínez, Núria; De Antonio Cuscó, Marta; Fernández-Sala, Xènia; Navarrete Rouco, Maria Eugenia; Colominas-González, Elena; Luque Pardos, Sònia; Fuster-Esteva, M.; Domingo, Laia; Sala Serra, Maria; Duran Jordà, Xavier, 1974-; Grau Cerrato, Santiago; Ferrández, Olivia (Frontiers, 2022)Introduction: Drug-related problems (DRP) are events or circumstances in which drug therapy does or could interfere with desired health outcomes. In December 2019, a new coronavirus, SARS-CoV-2, appeared. Little knowledge ...
-
Baré, Marisa; Lleal, Marina; Ortonobes, Sara; Queralt Gorgas, Maria; Sevilla-Sánchez, Daniel; Carballo Martínez, Núria; de Jaime Gil, Elisabet; Herranz, Susana; MoPIM study group (BioMed Central, 2022)Objectives: The objectives of the present analyses are to estimate the frequency of potentially inappropriate prescribing (PIP) at admission according to STOPP/START criteria version 2 in older patients hospitalised due ...
-
Carballo Martínez, Núria; García-Alzórriz, Enric; Ferrández, Olivia; Navarrete Rouco, Maria Eugenia; Duran Jordà, Xavier, 1974-; Pérez-García, Carolina; Monfort Faure, Jorge; Cots Reguant, Francesc; Grau Cerrato, Santiago (Frontiers, 2021)Rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis are chronic progressive immune-mediated rheumatic diseases (IMRD) that can cause a progressive disability and joint deformation and thus can impact in ...
-
Echeverría Esnal, Daniel; Martín-Ontiyuelo, Clara; Navarrete Rouco, Maria Eugenia; Barceló-Vidal, Jaime; Conde Estévez, David; Carballo Martínez, Núria; De Antonio Cuscó, Marta; Ferrández, Olivia; Horcajada Gallego, Juan Pablo; Grau Cerrato, Santiago (Taylor & Francis, 2022)Introduction: Aspergillus may cause different types of lung infections: invasive, chronic pulmonary or allergic bronchopulmonary aspergillosis. Pharmacological management with antifungals poses as a challenge. Patients ...
-
Martínez-Casanova, Javier; Carballo Martínez, Núria; Luque Pardos, Sònia; Sorli Redó, M. Luisa; Grau Cerrato, Santiago (Dove Medical Press, 2018)Azole antifungals have frequently been linked to the presence of hepatotoxicity, but there is scarce information on cross-toxicity between these drugs or on the possibility of using some of them when this type of toxicity ...
-
Carballo Martínez, Núria; Pérez-García, Carolina; Grau Cerrato, Santiago; Monfort, Jordi; Duran Jordà, Xavier, 1974-; Echeverría Esnal, Daniel; Ferrández, Olivia (Frontiers, 2022)Although several randomized clinical trials have confirmed that there is no difference in efficacy between etanercept and its biosimilar versions in the treatment of rheumatoid arthritis (RA), limited real-world evidence ...
Now showing items 1-10 of 10
© Universitat Pompeu Fabra | Plaça de la Mercè, 10-12. 08002 Barcelona | T. (+34) 93 542 20 00